SCHEMBL7084262

SCHEMBL7084262

N=C(N)c1ccc(CCC(=O)N2CCCc3cc(N(CCCC(=O)O)S(=O)(=O)c4cccc5ccccc45)ccc32)cc1

nearest known ligand 0.46

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
F2 P00734 5/20 0.46
ALDH1A1 P00352 2/20 0.40
PARP1 P09874 1/20 0.39
NR3C1 P04150 3/20 0.39
RORC P51449 1/20 0.37
F10 P00742 1/20 0.37
F7 P08709 1/20 0.37
POLB P06746 1/20 0.36
GAA P10253 1/20 0.36
ITGB3 P05106 1/20 0.36
ITGA2B P08514 1/20 0.36
PTPN11 Q06124 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6978671 0.92 F2 (0.46) F2ALDH1A1PARP1NR3C1RORC
SCHEMBL6981981 0.92 F2 (0.40) F2ALDH1A1PARP1NR3C1RORC
Hydrochloric Acid SCHEMBL7086319 0.87 F10 (0.42) F2ALDH1A1PARP1NR3C1RORC
SCHEMBL7084264 0.86 F2 (0.40) F2PARP1F10F7ITGB3
SCHEMBL7956920 0.85 F2 (0.46) F2ALDH1A1PARP1NR3C1RORC
Hydrochloric Acid SCHEMBL6979622 0.85 F2 (0.39) F2ALDH1A1PARP1NR3C1RORC
Hydrochloric Acid SCHEMBL7958487 0.85 NR3C1 (0.38) F2ALDH1A1PARP1NR3C1F10
Hydrochloric Acid SCHEMBL6980680 0.84 PARP1 (0.39) F2ALDH1A1PARP1NR3C1F10
Hydrochloric Acid SCHEMBL6984704 0.82 NR3C1 (0.49) ALDH1A1NR3C1POLBGAA
SCHEMBL6976662 0.82 F2 (0.60) F2ALDH1A1NR3C1POLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed